A randomized, double-blind, multicenter phase II AIO trial with gemcitabine plus sorafenib versus gemcitabine plus placebo in patients with chemotherapy-naive advanced or metastatic biliary tract cancer : First safety and efficacy data

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1571698600706527744
  • NII Article ID
    10030950654
  • Data Source
    • CiNii Articles

Report a problem

Back to top